SCHEMBL21647174

SCHEMBL21647174

COc1ccc2c(=O)c(C)c(-c3ccc(N4CCCCC4)cc3)oc2c1OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ ACHE P22303 2/20 0.44
▸ MAOA P21397 1/20 0.44
▸ LMNA P02545 2/20 0.43
▸ USP8 P40818 1/20 0.42
▸ ALOX5 P09917 2/20 0.42
▸ TERT O14746 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ PABPC1 P11940 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HTR1A P08908 2/20 0.40
▸ ADRA1A P35348 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ ADRA2A P08913 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21668602 0.88 ABCG2 (0.47) ALDH1A1KDM4EACHEMAOALMNA
SCHEMBL22789207 0.88 ACHE (0.43) ALDH1A1KDM4EACHEMAOAUSP8
SCHEMBL21668603 0.79 ABCG2 (0.49) ALDH1A1KDM4EACHEMAOALMNA
SCHEMBL21647149 0.79 CYP3A4 (0.63) ALDH1A1USP8TERTCYP1A2CYP3A4
SCHEMBL22772263 0.77 USP8 (0.51) ALDH1A1KDM4EACHEUSP8TERT
SCHEMBL21647185 0.77 USP8 (0.50) ACHEMAOAUSP8TERTGAA
SCHEMBL22789455 0.77 MAOA (0.44) ALDH1A1ACHEMAOALMNAUSP8
SCHEMBL27381294 0.70 MAOA (0.56) ALDH1A1KDM4EMAOATERTCYP1A2
SCHEMBL21647148 0.68 TERT (0.40) ALDH1A1KDM4EACHELMNATERT
SCHEMBL21668590 0.68 CDK2 (0.54) ALDH1A1KDM4ETERTABCG2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110790739-B Compounds for treating neurological diseases and uses thereof 陕西麦科奥特科技有限公司 2021-10-01 — — CN disclosed
EP-3831821-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF Shaanxi Micot Technology Limited Company (CN) 2021-06-09 — — EP disclosed
EP-3831821-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF Shaanxi Micot Technology Limited Company (CN) 2021-06-09 — — EP disclosed
US-20200390755-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF SHAANXI MICOT TECHNOLOGY CO., LTD. (CN) 2020-12-17 — — US disclosed
US-20200390755-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF SHAANXI MICOT TECHNOLOGY CO., LTD. (CN) 2020-12-17 — — US disclosed
CN-110790739-A Compounds for treating neurological diseases and uses thereof 陕西麦科奥特科技有限公司 2020-02-14 — — CN disclosed
WO-2020024977-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF 陕西麦科奥特科技有限公司 2020-02-06 — — WO disclosed
WO-2020024977-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF 陕西麦科奥特科技有限公司 2020-02-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200390755-A1 COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF MAPT, PYGB, SLC6A2 ALDH1A1 787/4885KDM4E 4063/4885ACHE 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback